ADGM
Adagio Medical Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.56
+3.55%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | — | — | 269.0K | 300.0K | 189.0K |
| Cost of Revenue | 89.0K | 684.0K | 1.9M | 1.3M | 875.0K |
| Gross Profit | (89.0K) | (684.0K) | (1.7M) | (1.0M) | (686.0K) |
| Operating Expenses | |||||
| R&D Expense | 10.2M | 10.6M | 4.6M | 15.4M | 17.9M |
| SG&A Expense | 9.5M | 10.6M | 7.0M | 11.5M | 5.4M |
| General & Admin Expense | 2.5M | — | — | 4.8M | — |
| Selling & Marketing Expense | — | — | — | 6.8M | — |
| Other Expenses | — | — | 49.2M | — | — |
| Total Operating Expenses | 19.7M | 21.2M | 60.8M | 26.9M | 23.2M |
| Cost and Expenses | 19.8M | 21.9M | 62.7M | 28.2M | 24.1M |
| Operating Income (EBIT) | (19.8M) | (21.9M) | (62.5M) | (27.9M) | (23.9M) |
| Non-Operating | |||||
| Interest Income | 390.0K | 477.0K | 423.0K | 3.0K | 39.0K |
| Interest Expense | 3.1M | 2.9M | (1.1M) | 1.7M | 137.0K |
| Net Interest Income | (2.7M) | (2.4M) | 1.5M | (1.7M) | (98.0K) |
| Other Non-Op Income/Expense | (7.3M) | (3.2M) | 8.7M | (10.2M) | 240.0K |
| Non-Operating Income (excl Interest) | 4.2M | 288.0K | (7.6M) | 8.5M | (377.0K) |
| EBT (Pre-Tax Income) | (27.1M) | (25.1M) | (53.8M) | (38.1M) | (23.7M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (27.1M) | (25.1M) | (53.8M) | (38.1M) | (23.7M) |
| Earnings from Cont. Ops | (27.1M) | (25.1M) | (53.8M) | (38.1M) | (23.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (27.1M) | (25.1M) | (53.8M) | (2.1M) | (23.7M) |
| Per Share | |||||
| Basic EPS | ($1.43) | ($1.51) | ($3.54) | ($0.16) | ($1.23) |
| Diluted EPS | ($1.43) | ($1.51) | ($3.54) | ($0.16) | ($1.23) |
| Revenue Per Share | $0.00 | $0.00 | $0.02 | $0.02 | $0.01 |
| Shares | |||||
| Basic Shares Outstanding | 22.2M | 16.6M | 15.2M | 13.4M | 19.2M |
| Diluted Shares Outstanding | 22.2M | 16.6M | 15.2M | 13.4M | 19.2M |
| Profitability Metrics | |||||
| EBITDA | (23.2M) | (21.2M) | (53.5M) | (36.0M) | (23.0M) |
| D&A | 839.0K | 970.0K | 1.4M | 532.0K | 495.0K |
| EBIT | (24.0M) | (22.2M) | (54.9M) | (36.5M) | (23.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026